Alogliptin-containing products (Nesina®, Oseni®, Kazano®) – New Warning
December 12, 2016 – The FDA approved a new update to the Warnings and Precautions section of the Nesina (alogliptin), Kazano (alogliptin/metformin), and Oseni (alogliptin/ pioglitazone) drug labels regarding bullous pemphigoid.
Download PDF
